rs776242631
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_000751.3(CHRND):c.53-16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,613,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
CHRND
NM_000751.3 intron
NM_000751.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.175
Publications
0 publications found
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
CHRND Gene-Disease associations (from GenCC):
- congenital myasthenic syndrome 3AInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital myasthenic syndrome 3BInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- congenital myasthenic syndrome 3CInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-232526513-C-T is Benign according to our data. Variant chr2-232526513-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1643030.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRND | NM_000751.3 | c.53-16C>T | intron_variant | Intron 1 of 11 | ENST00000258385.8 | NP_000742.1 | ||
CHRND | NM_001256657.2 | c.53-16C>T | intron_variant | Intron 1 of 10 | NP_001243586.1 | |||
CHRND | NM_001311196.2 | c.-219-16C>T | intron_variant | Intron 1 of 11 | NP_001298125.1 | |||
CHRND | NM_001311195.2 | c.-219-16C>T | intron_variant | Intron 1 of 9 | NP_001298124.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152216Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
13
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000320 AC: 8AN: 250238 AF XY: 0.0000221 show subpopulations
GnomAD2 exomes
AF:
AC:
8
AN:
250238
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000153 AC: 224AN: 1461108Hom.: 0 Cov.: 33 AF XY: 0.000142 AC XY: 103AN XY: 726870 show subpopulations
GnomAD4 exome
AF:
AC:
224
AN:
1461108
Hom.:
Cov.:
33
AF XY:
AC XY:
103
AN XY:
726870
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33474
American (AMR)
AF:
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
26136
East Asian (EAS)
AF:
AC:
3
AN:
39700
South Asian (SAS)
AF:
AC:
4
AN:
86238
European-Finnish (FIN)
AF:
AC:
0
AN:
52744
Middle Eastern (MID)
AF:
AC:
0
AN:
5722
European-Non Finnish (NFE)
AF:
AC:
207
AN:
1111996
Other (OTH)
AF:
AC:
3
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
13
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
5
AN:
41574
American (AMR)
AF:
AC:
0
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5176
South Asian (SAS)
AF:
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68034
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.579
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Lethal multiple pterygium syndrome Benign:1
Sep 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.